LB943 Prediction of super response and drug-free disease control in guselkumab patients using multivariate baseline serum biomarkers: data from part 3 of GUIDE trial

Autor: Chen, Y., Angsana, J., Yum, N., Tabori, S., Krüger, N., Spindler, N., Wegner, S., Sabat, R., Pinter, A., Weisenseel, P., Asadullah, K., Schäkel, K., Eyerich, K., Keyes, B., Leung, M.W.
Zdroj: In Journal of Investigative Dermatology August 2024 144(8) Supplement:S165-S165
Databáze: ScienceDirect